Company intelligence / Profile preview

Jingfeng Medical

Shenzhen, Guangdong Province, Chinaethercat.org ↗

Ownership: Private
Development stage: Commercial

Overview

First preclinical experience with the EDGE SP1000 single-port robotic system-assisted transanal total mesorectal excision reported in literature. Animal testing began for bronchoscope robot in January 2022. Stereoscopic endoscope approved by Guangdong Provincial Drug Administration in October 2022

Therapeutic areas: OtherGastroenterology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Cooperation with hospitals across China to set up training centers for surgeons using their robots

Beyond the preview

Go deeper on Jingfeng Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingfeng Medical.

Explore the full profile